tiprankstipranks
Trending News
More News >
Kuros Biosciences Ltd. (CH:KURN)
:KURN

Kuros Biosciences (KURN) Revenue

Compare
7 Followers

Kuros Biosciences Revenue

Kuros Biosciences had a revenue of 66.04M in the quarter ending Dec 31, 2025, with 4.04%. This bring the company's revenue in the last twelve months to 129.52M, Decreased 20.83%. In the fiscal year ending Dec 31, 2025, Kuros Biosciences had annual revenue of 121.30M with 60.54% growth.
Revenue (ttm)
129.52M
Revenue Growth
104.01%
P/S Ratio
7.53
Revenue/Employee
CHF994,255
Employees
122
Market Cap
CHF913.66M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
121.30M45.74M+60.54%
Dec 31, 2024
75.56M41.99M+125.11%
Dec 31, 2023
33.56M15.58M+86.61%
Dec 31, 2022
17.99M4.17M+30.19%
Dec 31, 2021
13.81M9.78M+242.04%
Dec 31, 2020
4.04M1.48M+57.71%
Dec 31, 2019
2.56M1.85M+258.18%
Dec 31, 2018
715.00K181.00K+33.90%
Dec 31, 2017
534.00K